Yu Lu

State Key Laboratory Of Systems Medicine For Cancer
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Dietary vitamin B3 supplementation induces the antitumor immunity against liver cancer via biased GPR109A signaling in myeloid cell.

Dietary vitamin B3 supplementation induces the antitumor immunity against liver cancer via biased GPR109A signaling in myeloid cell.

Journal: Cell reports. Medicine

Published: February 26, 2024

Intranasal esketamine versus esketamine-dexmedetomidine combination for premedication in pediatric patients undergoing strabismus surgery: a randomized controlled trial.

Intranasal esketamine versus esketamine-dexmedetomidine combination for premedication in pediatric patients undergoing strabismus surgery: a randomized controlled trial.

Journal: Translational pediatrics

Published: February 18, 2024

Hypoxia-induced degradation of PICK1 by RBCK1 promotes the proliferation of nasopharyngeal carcinoma cells.

Hypoxia-induced degradation of PICK1 by RBCK1 promotes the proliferation of nasopharyngeal carcinoma cells.

Journal: Life sciences

Published: January 23, 2023

Activation of uroepithelial 5-HT4R inhibits mechanosensory activity of murine bladder afferent nerves.

Activation of uroepithelial 5-HT4R inhibits mechanosensory activity of murine bladder afferent nerves.

Journal: Frontiers in physiology

Published: July 09, 2022

Efficacy of premedication with intravenous midazolam on preoperative anxiety and mask compliance in pediatric patients: a randomized controlled trial.

Efficacy of premedication with intravenous midazolam on preoperative anxiety and mask compliance in pediatric patients: a randomized controlled trial.

Journal: Translational pediatrics

Published: April 13, 2022

Low-dose X-ray irradiation combined with FAK inhibitors improves the immune microenvironment and confers sensitivity to radiotherapy in pancreatic cancer.

Low-dose X-ray irradiation combined with FAK inhibitors improves the immune microenvironment and confers sensitivity to radiotherapy in pancreatic cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 23, 2022

Hypoxic Cell-Derived Extracellular Vesicles Aggravate Rectal Injury Following Radiotherapy via MiR-122-5p.

Hypoxic Cell-Derived Extracellular Vesicles Aggravate Rectal Injury Following Radiotherapy via MiR-122-5p.

Journal: Frontiers in cell and developmental biology

Published: March 09, 2022

Perioperative Low Dose Dexmedetomidine and Its Effect on the Visibility of the Surgical Field for Middle Ear Microsurgery: A Randomised Controlled Trial.

Perioperative Low Dose Dexmedetomidine and Its Effect on the Visibility of the Surgical Field for Middle Ear Microsurgery: A Randomised Controlled Trial.

Journal: Frontiers in pharmacology

Published: August 19, 2021

New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer.

New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: June 07, 2018

Application of the Eighth Edition of the American Joint Committee on Cancer Staging for Pancreatic Adenocarcinoma.

Application of the Eighth Edition of the American Joint Committee on Cancer Staging for Pancreatic Adenocarcinoma.

Journal: Pancreas

Published: June 01, 2018

Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma.

Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: December 05, 2017

Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions.

Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions.

Journal: Journal of hematology & oncology

Published: November 12, 2017

Showing 1-12 of 26

Last Updated: 09/26/2026